<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 266 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page265.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=266">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 266 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 266</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=266"><img src="../thumb/266.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Anti-Microbials - 18.1.2                                                       2020-04 / 229
       Side effects: GI disturbs., pseudomembr.colit., allerg.reacts.incl.  Dosage: Admin.½.hr.aft.food.  Side-effects: Bld.dyscras., headache, trans. incr. in hepat. enzym.
       drug fev./angioed./anaphylax., skin/ser.-sickn.-like reacts., vaginit.,   Adults: Sinusit., ac.& chron.bronchit: 250 mg 2xdly x7 days.   lev., GI disturbs., skin reacts. incl.erythema multiforme/Stev.-John-
       vag.disch., genit.prurit./monilias., headache, dizzin., convuls., fatig.,   (Range 5-10 days)  son & tox.epiderm.necrolys., vag.candidias., hypersens. reacts.incl.
       tox.psychos., bld.dyscras., hepatit., cholestat. jaund.  Ac.uncomplicat.cystit: 125 mg 2xdly x7 days. (Range 5-10 days)  bronchospasm/ anaphylax., ac.ren.fail., Jarisch-Herxheim.react. fol-
       Special precautions: Cross.placenta, excret.in breast milk, GI dis.  Lyme dis: Adults & childr.over 12 yrs: 500 mg 2xdly x20 days  low.Lyme dis.treatm.
       hist., hypersens., known allerg. hist., superinfect.with prolong.use,   Childr: 3 mnths-2 yrs: 125 mg 2xdly. Over 2 yrs: 250 mg 2xdly.  Special precautions: GI dis.hist.esp.ulcerat. colit., discont.ther.if
       discont.ther./ appropr. treatm.in case of allerg.reacts./ pseudomembr.   Contraindications: Penicill.& other ß-lactam hypersens., safety &   pseudomembr.colit.suspect., Crohn’s dis., ren.funct.monit.recomm
       colit., imp.ren.funct., concom.OC’s.  effic.in pregn.& lactat.not est., safety in porphyr.not est., no exper.  in imp.ren. funct.pts., avoid concom.furosemide, poss. penicill. /
       Drug interactions: Decr.OC effic., incr. nephrotoxic. risk with other   in childr. und.3 mnths.  cephalospor.cross.sens., monit.bone marr. respons.in pts.develop.
       nephrotox.meds.               Side effects: Pseudomembr.colit., bld.dyscras., headache, GI dis-  decr.HB conc., super-infect.
       AURO CEFEPIME, Aurobindo [P/S]  turbs., vag.candidias., skin reacts.incl.erythema multiforme/ Stev.  Drug interactions: Probenecid incr.ser.lev.& delays excret., furo-
                                     Johns. syndr./ tox.epiderm.necrolys., hypersens.reacts. incl.bron-
       Cefepime                      chosp./anaphylax.            semide enhanc. nephrotox. potent., nephrotoxic.risk incr.with con-
                                                                  com. aminoglycos. & other cephalospor.
       Indications: Adults: LRT incl.nosocom.& commun. acquir.pneum.,   Special precautions: GI dis.hist.esp.ulc.colit./ region.enterit./
       ac.bact.exacerbat.of chron. bronchit., ac.bronch., complic.& uncom-  pseudomembr.colit., ren.funct. impairm., discont.ther.with suspect.  CEFASYN, (Cipla Medpro) Alkem [P/S]
       plic. UTI, skin & skin struct., & complic.intra-abdom. infects caus.by   pseudomembr. colit., superinfect.with prolong.use, Jarisch-Herx-  Cefuroxime axetil.equiv.to cefuroxime.
       suscept.bact.incl.peritonit./bil. tract infects., empiric monother.of fe-  heim.react.in Lyme dis.  Indications: Pharyngit., tonsillit., otit.media, sinusit., ac.& chron.
       brile neutropen. using combinat.ther.with another approp.antimicrob.  Drug interactions: Probenecid incr.AUC.  bronchit., ac.uncomplic.cystit.& Lyme dis.in adults & childr.over 12 yrs.
       agent in pts.at high risk of sev. infect.                  (S4) TABS, 45/20.1.1/0216,0217
       Childr.2 mnths.& old: LRT, UTI, skin & skin struct., empiric mono-  AUSTELL-CEFOTAXIME, Austell [P/S]  718658-001: 250 mg, 10, R128,28
       ther.of febrile neutropen. using combinat.ther.with another approp.   Cefotaxime sodium  718659-001: 500 mg, 10, R223,10
       antimicrob. agent in pts.at high risk of sev.infect.  Indications: URT/urin.tract & GIT suscept.organ. infects., Neisseria   Dosage: Admin.½.hr.aft.food.
       (S4) INJ. 41/20.1.1/0690, 0691  meningitides in childr., ac. uncomplicat.cystit., reduc.incid.of post-op   Sinusit., ac.& chron.bronchit: 250 mg 2xdly x7 days. (Range
       713369-001: 1 g, sngl.vial, R129,52  infects. in potent.contaminat.surg.proced.  5-10 days)
       713370-001: 2 g, sngl.vial, R264,16  (S4) INJ. 37/20.1.1/0364, 0365  Ac.uncomplicat.cystit: 125 mg 2xdly x7 days. (Range 5-10 days)
       Dosage: Admin.IV/IM depend.on suscept of organ. /sev.of infect./  707289-001: 500 mg, 1 vial, R15,86  Lyme dis: Adults & childr.over 12 yrs: 500 mg 2xdly x20 days
       overall condit.& ren.funct. Admin.by slow IV inj.over 3-5 mins.OR IV in-  707290-001: 1 g, 1 vial, R26,97  Contraindications: Penicill.& other ß-lactam hypersens.
       fus.of 50-100 ml over approx. 30 mins. Usual durat.of ther: 7-10 days.   Dosage: Admin.IM/IV. IV infus: Disolv.in 40-100 ml & infus.IV over   Side effects: Bld.dyscras., hypersens.reacts.incl. anaphylax., head-
       More sev.infects.may require long. treatm.  20-60 mins. Dos.,route of admin.& freq.depend on nature, sev.of in-  ache, dizzin., GI disturbs., trans hepat.enzyme lev.incr., jaund., erythe-
       Adults & childr.12 yrs & old with norm.ren. funct.: Recomm.dos:   fect., condit. of pt.& sensitiv.of pathog.  ma multiforme /Stev.Johns & tox.epiderm.necrolys., vag.candidias.
       Mild to mod.complic./uncomplic.UTI: 500 mg-1 g IV/IM 12 hrly.  Adults: 1 g 12 hrly. Sev: 3-4 g dly in 2-4 admin., with up to 12 g IV   Warnings and special precautions: GI dis.hist., ren.funct.im-
       Mild to mod.infects.incl.bronchit., skin & skin struct.infects:   in very sev.cases.  pairm., porphyr., investig.for poss. pseudomembr.colit.if suspect.,
       1 g IV/IM 12 hrly.            Neonates: 0-1 wk: 50 mg/kg bm IV 12 hrly. 1-4 wks: 50 mg/kg bm   poss.penicill.& cephalospor.cross.sens., overgrowth of non-suscept.
       Sev.infects: 2 g IV 12 hrly.   IV 8 hrly. Childr: 50 -100 mg/kg bm/day 2-4 inj.& in except.cases   organ.with prolong.use, Jarish-Herxheim. react.report.follow.Lyme
       Empir.fev.in neutropen.pts: 2 g IV 8 hrly. x7 days /resol.of neu-  up to 200 mg/kg/ day.  dis.treatm., safety in pregn.& lactat.not est.
       tropen.                       Contra-indications: Penicillin hypersens., safety in pregn.& lac-  Drug interactions: Probenecid incr.AUC, OC effic.poss.reduc.
       Paed.pts.1 mnth up to 12 yrs.  tat.not est.
       Pneumon.,UTI & skin struct.infects: Paed.pts. &gt;2 mnths.&   Side-effects: Bld.dyscras., arrythm.follow.rapid bolus infus.through   CEPODEM, Ranbaxy [P/S]
       body weight&lt; 40 kg: 50 mg/kg 12 hrly x 10 days. More sev.in-  centr.ven.catheter, headache, confus., encephalopathy, GI disturbs.,   Cefpodoxime proxetil equiv.to cefpodoxime.
       fects: 8 hrly.dos. sched.     decr.ren. funct. partic.with aminoglycos., trans.hepat. enzyme incr.,   Indications: Suscept.URTI/LRTI, commun.acquir. pneum.in adults.
       Empir.febrile neutropen: Paed.pts.&gt; 2 mnths. &lt; 40 kg: 50 mg/kg   loc.reacts., skin reacts.incl.erythema multiforme/Stev.John.syndr./tox.  (S4) TABS, [P/S] 36/20.1.1/0225, 0226
       8 hrly x7-10 days. Exper.limit. in paed.pts. &lt; 2 mnths of age.  epiderm.necrolys., hypersens.reacts.incl.anaphylax., superinfects.,   703056-001: 100 mg, 10, R122,14
       Paed.pts. 1-2 mnths: 30 mg/kg 12 hrly or 8 hrly may be consid.   poss Jarisch-Herxheimer react.  703057-001: 200 mg, 10, R135,85
       Monit.admin.caref.            Special precautions: Penicill.cross-sens., Na content in Na restrict.  Dosage: Admin.with meals. Admin.for min of 10 days in ß-haemolyt.
       Paed.pts. &gt; 40 kg: recomm.adult dos.applies.  pts., monit.WBC for treatm. long.than 10 days & discont.if neutro-  streptococc.infects. Depend.on condit:
       Old.than 12 yrs.&lt; 40 kg: Dos.for young.pts. &lt; 40 kg. Paed.dos.not   pen.develops, pseudomembr.colit., GI dis hist.esp.ulcerat.colit./ reg.  Adults: 100-200 mg 12 hrly.
       to exceed the max.recomm. adult dos.of 2 g 8 hrly.  enterit/antibiot.assoc.colit., ren.funct.impairm., porphyr., do not mix   (S4) SUSP, [P/S] 36/20.1.1/0227. 40 mg/5 ml.
       Exper.in IMI admin.in paed.pts.limit.  with other antibiot.in syr./ infus.  703058-001: 50 ml, R85,45
       Contraindications: Safety in pregn.& lactat. not est.  Drug interactions: Enhanc.nephrotoxic.with nephrotox.meds./diuret.  703058-002: 100 ml, R170,86
       Side effects: Bld.dyscras., aplast.anaem., haemorrh., anaphylax.,   Dosage: Childr.over 1 yr: 8 mg/kg/day in 2 div.dos.at 12 hrly interv.
       fev., headache, dizzin., seiz., paraesthes., vasodilat., dyspn., chills,   AUSTELL-CEFTRIAXONE, Austell [P/S]  Contraindications: Safety in pregn.& lactat.not est., safety & ef-
       GI disturbs., oral monilias., pseudomembr.colit., taste pervers., hep-  Ceftriaxone sodium  fic.in childr.&lt;1 yr.not est.
       atit., cholestat.jaund., skin reacts.incl. tox. epiderm.necrolys./ery-  Indications: Bact.septicaem./meningit./intra abdom. infects./skin &   Side effects: Bld.dyscras., anaphylact.reacts., loss of appetite,
       them.multiform./ Stev. John. syndr., vaginit., genit.prurit., loc.reacts.  skin struct./bone & joint/ ren. & urin.tract/ resp.tract & ENT infects.  headaches, paraesthes., dizzin., tinnit., GI disturbs., liv.damage, rash,
       incl. phlebit. /inflamm.at IV & IM inj.site, superinfect., encephalopa-  caus.by suscept. organ., uncomplic.gonorrh., peri-op.infect. prophylax.  prurit., urticar., Stev.John.syndr. tox.epiderm.necrolys, erythema mul-
       thy/ myoclonus., colit.       (S4) INJ. 39/20.1.1/0176     tiforme, asthen., malaise.
       Special precautions: Allerg.reacts.esp.meds., prev. ß-lactam/  707288-001: 1 g, 1, R30,82  Warnings and special precautions: Penicill.& ß-lactam cross
       penicill.hypersens., discont.ther.in allerg. reacts.& treat appropr.,   Dosage: Admin.IM/IV. IV inj.over 2-4 mins. & IV infus.over at least   sensitiv., super infect., poss. develolpm. of pseudomembran.colit.,
       imp.ren.funct./ condits. comprom.ren.funct., pseudomembr.colit.,   30 mins. Durat.of ther.for min. of 48-72 hrs.aft.pt.afebr./bact.eradicat.  ren.impairm., lact./sucrose intol.
       appropr. treatm.in case of superinfect., monit.ren. funct. esp.with   Adults & childr.over 12 yrs: 1-2 g once dly. Max: 4 g dly. Neo-  Drug interactions: Antacids & histam.H 2 recept. anagon. decr.ab-
       concom. nephrotox., elderly with ren. funct.impairm.  nates up to 14 days: 20-50 mg/kg bm once dly. Max: 50 mg/kg   sorpt., probenec.reduc.excret.
       Drug interactions: Incompat.when admix.with vancomycin HCl/   dly. Not necess.to different. betw.prem.& term infts. Infts.& childr.
       gentamycin sulph./ aminophylline.  (15 days to 12 yrs): 20-80 mg/kg bm once dly. Childr.with bm 50 kg   CEROXIM, Ranbaxy [P/S]
                                     or more: Usual adult dos.
       AUROPROZIL, Actor Pharma [P/S]  Bact.meningit: Neonates, infts.& childr: Init. 100 mg/kg (not to   Cefuroxime axetil.equiv.to cefuroxime.
                                                                  Indications: Pharyngit., tonsillit., otit.media, sinusit., bronchit.,
       Cefprozil monohydrate equiv.to cefprozil.  exceed 4 g) once dly., adapt dos. accord. once organ.& sens.deter-  ac.uncomplic. cystit.& Lyme dis.in adults & childr.over 12 yrs.
       Indications: Mild to mod.sev.U&LRT, otit.med., sinusit., skin & skin   min. Adults: 4 g once dly.  (S4) TABS, 34/20.1.1/0349, 0350
       struct., and UT infects.caus.by suscept. organ.  Gonorrh: 125 mg IM as sngl.dos.  700689-001: 250 mg, 10, R121,63
       (S4) TABS, 41/20.1.1/0043, 0044  Periop.-prophylax: Sngl.dos.of 1-2 g 30-90 mins. prior to surg.  700687-001: 500 mg, 10, R223,05
       715059-001: 250 mg, 10, R145,23  Contra-indications: Penicill.cross-sens., safety in pregn.& lac-  (S4) SUSP, 45/20.1.1/0965
       715075-001: 500 mg, 10, R239,94  tat.not est.              723411-001: 125 mg/5 ml, 50 ml, R69,28
       Dosage: Admin.over 10 days.   Side-effects: GI disturbs., pseudomembr.colit., Ca salts precipit.  723411-002: 125 mg/5 ml, 100 ml, R138,56
       Adults & childr.over 12 yrs:  in galbladd., haematoma/bleed., bld. dyscras., prolong. prothromb.  (S4) FORTE SUSP, 45/20.1.1/0966
       URTI: 500 mg every 24 hrs.    time, skin reacts. incl. Stevens Johnson syndr., dizz., headache, ol-  723415-001: 250 mg/5 ml, 50 ml, R138,56
       LRTI: 500 mg 12 hrly.         igur., genit.mycos., poss.drug precip.in kidn., anaphylact. / loc.reacts.,   723415-002: 250 mg/5 ml, 100 ml, R277,13
       Sinusit: 250 or 500 mg 12 hrly.  fev., shiver., superinfect., shadows detect.by gallbladd.sonogram   Dosage: Admin.2xdly ½.hr.aft.food x5-10 days. Due to bitter taste
       Uncomplic.UTI: 500 mg every 24 hrs.  mistak.for gallston. usual. follow.high.than recomm.dos., pancreatit.  don’t crush tabs.
       Skin/skin struct.infects: 250 mg 12 hrly.or 500 mg 12 or 24 hrly.  Special precautions: Cross.placenta & excret. in breast milk, sev.  Adults:
       Contraindications: Penicillin cross-sens., prev. hypersens.reacts.,   ren.fail., do not add to sols. contain. Ca, incompat.with vancomyc./  Pharyngit./tonsillit./sinusit.& bronchit: 250 mg.
       childr.und.1 yr., safety in pregn. & lactat.not est.  fluconazole & aminoglycosides, neonates esp.prems.at risk of de-  Otit.med: 500 mg
       Side effects: Bld.dyscras., angioed., anaphylax., fev., CNS effs.,   velop. bilirubin encephalopathy  Ac.uncomplicat.cystit: 250 mg.
       headache, GI disturbs., cholestat. jaund., skin reacts.incl.Stev.John.  Childr:
       syndr., ser. sickn., superinfect., genit.prurit.& vaginit.   BETAROXIME, (Unicorn) Be-Tabs [P/S]  Usual dos: 125 mg 2xdly.x7 days. Range: 5-10 days.
       Special precautions: Poss.pseudomembr.colit., prophylact.vit.K   Cefuroxime axetil  Pharyngit./tonsillit: 10 mg/kg to max.125 mg 2xdly x7 days with
       with prolong.use in malnour./ seriously ill.pts., eval.ren.status bef.  Indications: Pharyngit., tonsilit., otitis media, sinusit., ac.& chron.bron-
       init.& dur. ther. in known/suspect.ren.funct.impairm., concurr. potent.  chit., ac.uncomplicat. cystit. infects.caus.by suscept.organ., Lyme dis.  range of 5-10 days.
                                                                  Otitis media: 3 mnths-2 yrs: 125 mg 2xdly x5-10 days. Over 2 yrs:
       diuret.therapy, non-suscept. organ.overgrowth   (S4) TABS, 41/20.1.1/0139
       Drug interactions: Poss.inhibit.of Vit.K synthes., nephrotoxic.with   710531-001: 500 mg, 10, R218,44  250 mg 2xdly. x7 days. Range: 5-10 days.
                                                                  Lyme dis: Adults & childr.over 12 yrs: 500 mg 2xdly x14 days.
       concom.aminoglycos. & other cephalospor.  Dosage: Admin. ½ hr.aft.food.
                                     Adults: Sinusit., ac.or chron.bronchit: 250 mg 2xdly x 7 days   Range 10-21 days.
       AUROXIME, Aurobindo [P/S]     (range 5-10 days)            Contraindications: Penicill.& other ß-lactam hypersens.
       Cefuroxime axetil equiv.to cefuroxime  Ac.uncomplic.cystit: 125 mg 2xdly x 7 days (range 5-10 days)  Side effects: Candida overgrowth, oral thrush, vaginit., bld.dyscras.,
       Indications: U&LRTI, otit.media, ac.uncomplic. cystit.& Lyme dis.  Lyme dis: Adults & childr.over 12 yrs: 500 mg 2xdly for 20 days  hypersens.reacts.incl skin reacts., urticar., prurit., cutan.vasculit., bron-
       caus.by suscept.organ.        Childr.3 mnths-2 yrs: 125 mg 2xdly. Over 2 yrs: 250 mg 2xdly.   chosp., drug fev., ser.sickn., anaphylax., headache, convuls., GI dis-
       (S4) TABS, A40/20.1.1/0720; 0721  Contra-indications: Penicill.& other ß-lactam antibiot. hypersens.,   turbs., pseudomembr.colit., hear. loss.in childr.with menigit., choles-
       713531-001: 250 mg, 10, R126,38  safety & effic.in pregn.& lactat. not est., safety in porphyr.not est., no   tat.jaund., hepatit., erythema multiforme/Stev.John.& tox. epiderm.
       713532-001: 500 mg, 10, R250,36  exper. in childr.und.3 mnths.for tabs.  necrolys., porphyr., ac.interstit.nephrit., nephrotoxic.,</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page265.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page261.html">261</a>&nbsp;&nbsp;&nbsp;<a href="page262.html">262</a>&nbsp;&nbsp;&nbsp;<a href="page263.html">263</a>&nbsp;&nbsp;&nbsp;<a href="page264.html">264</a>&nbsp;&nbsp;&nbsp;<a href="page265.html">265</a>&nbsp;&nbsp;&nbsp;<a href="page266.html">266</a>&nbsp;&nbsp;&nbsp;<a href="page267.html">267</a>&nbsp;&nbsp;&nbsp;<a href="page268.html">268</a>&nbsp;&nbsp;&nbsp;<a href="page269.html">269</a>&nbsp;&nbsp;&nbsp;<a href="page270.html">270</a>&nbsp;&nbsp;&nbsp;<a href="page271.html">271</a>
             </td>
             <td width="35%"><a href="page267.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page267.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
